Data / Form D filings / Virax Biolabs Group Ltd
Virax Biolabs Group Ltd: Form D filings
Virax Biolabs Group Ltd, a biotechnology company in Lanarkshire, United Kingdom, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on December 18, 2025, reports $5 million sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- BioCity Glasgow, Bo'Ness Road Newhouse, Lanarkshire, United Kingdom, ML1 S
- Phone
- 44 020 7788 7414
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Cayman Islands
- Year incorporated
- 2021
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1885827
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | New notice | $5,000,000 | $5,000,000 | 1 | Dec 3, 2025 | sec.gov | |
| Oct 17, 2023 | New notice | $2,150,000 | $2,150,000 | 1 | Oct 12, 2023 | sec.gov | |
| Mar 15, 2023 | New notice | $4,000,000 | $4,000,000 | 1 | Mar 10, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yair Erez | Director | |
| Evan Norton | Director | |
| Nigel McCracken | Executive Officer, Director | |
| James Foster | Executive Officer, Director | |
| Nelson Haight | Director |
Every Form D from the week of Dec 15, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Virax Biolabs Group Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.